Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Molecular evaluation of residual disease following neoadjuvant chemotherapy in triple-negative breast cancer CALGB 40603 (Alliance)

BACKGROUND Despite therapeutic advances in early-stage triple-negative breast cancer (TNBC), residual disease (RD) following neoadjuvant therapy remains a key predictor of a worse prognosis and obstacle to improving patient outcomes. METHODS To better characterize RD and identify survival-associated features, we perfor...

P. D. Rädler, B. Felsheim, A. Fernández-Martínez et al. · 0 citations
Open access Aug 2026

Integrative Transcriptional and Chromatin Analyses Reveal Enhancer-Mediated Regulatory Programs Driving Breast Cancer Metastasis

A multi-omic resource integrating transcriptomic and chromatin accessibility profiles from estrogen receptor-positive primary breast tumors and matched liver and lung metastases obtained from the same patients, revealing new regulatory vulnerabilities that may be therapeutically exploitable.

Frances L. Heredia, Natalia Maldonado-Vazquez, H. Fogle et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.